Visualitza per autor "Calvo, Emiliano"
Ara mostrant els elements 1-2 d 2
-
Phase 1 first-in-human dose-escalation study of ANV419 in patients with relapsed/refractory advanced solid tumors
Joerger, Markus; Calvo, Emiliano; Laubli, Heinz; Lopez, Juanita; Alonso-Casal, Guzman; Corral de la Fuente, Elena; GARRALDA, Elena (BMJ, 2023-11) -
Safety and activity of the TGFβ receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer
Hollebecque, Antoine; Varghese, Anna; Borazanci, Erkut; Macarulla Mercadé, Teresa; Oh, Do-Youn; Melisi, Davide; Calvo, Emiliano (BMJ Publishing Group, 2021-03-09)